Loading…

5053 POSTER Randomized Phase III Study of First-line Bevacizumab in Combination With Capecitabine or Paclitaxel for HER2-negative LR/MBC: Interim Safety Data

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2011, Vol.47, p.S346-S346
Main Authors: Inbar, M, Lang, I, Kahán, Z, Greil, R, Beslija, S, Stemmer, S.M, Kaufman, B, Zvirbule, Z, Steger, G.G, Zielinski, C.C
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(11)71495-2